PIN14 ECONOMIC EVALUATION OF CASPOFUNGIN (CANCIDAS®) VERSUS LIPOSOMAL AMPHOTERICIN B FOR EMPIRICAL THERAPY OF SUSPECTED SYSTEMIC FUNGAL INFECTION IN THE GERMAN HOSPITAL SETTING
Abstract
Authors
P Kaskel S Tuschy A Wagner C Bannert OA Cornely A Glasmacher P Lütkes HP Lipp AJ Ullmann